SBRI19015U Clinical Translational Medicine

Upon completing the course, participants should be able to:

Knowledge

• Understand how comprehensive characterisation of individual patients or their samples –using molecular, immunological, genetic, and proteomic analyses – can guide personalised treatment strategies.
• Explain how findings from biological experiments (e.g., in vitro studies and animal models) can inform the design of clinical investigations.
• Discuss how biological research contributes to the drug development process.
• Understand the process of advancing a preclinical drug candidate to a Phase 1 clinical trial.

Skills

• Integrate knowledge obtained from other courses into translational clinical research.
• Critically evaluate preclinical data – from a clinical point of view.
• Generate novel ideas for clinical trials from preclinical observations.
• Implement research results in clinical practice.
• Solve unmet clinical needs/questions by designing the clinically relevant preclinical/ biological experiments.
• Practice how to be a moderator of a scientific discussion.
   

Competences

• Integrate basic biology into clinical knowledge.
• Assess ethical considerations of how to implement new molecular tools and conduct studies with patients.
• Understand the central aspects of clinical translational medicine and be able to discuss and communicate these to other scientists, clinicians, and the public.